Table 1. Primary CD56+ NK Cells Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Primary CD56+ NK Cells Market Restraints

Table 3. Primary CD56+ NK Cells Market Trends

Table 4. Primary CD56+ NK Cells Industry Policy

Table 5. Global Primary CD56+ NK Cells Revenue by Company, 2018-2023, US$ million

Table 6. Global Primary CD56+ NK Cells Revenue Market Share by Company, 2018-2023

Table 7. Global Primary CD56+ NK Cells Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Primary CD56+ NK Cells Sales Volume Market Share by Company, 2018-2023

Table 9. Global Primary CD56+ NK Cells Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Primary CD56+ NK Cells Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Primary CD56+ NK Cells Mergers & Acquisitions, Expansion Plans

Table 12. Global Primary CD56+ NK Cells Manufacturers Product Type

Table 13. China Primary CD56+ NK Cells Revenue by Company, 2018-2023, US$ million

Table 14. China Primary CD56+ NK Cells Revenue Market Share by Company, 2018-2023

Table 15. China Primary CD56+ NK Cells Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Primary CD56+ NK Cells Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Primary CD56+ NK Cells Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Primary CD56+ NK Cells Import & Export Trends

Table 19. Main Sources of China Primary CD56+ NK Cells Import

Table 20. Export Destination of China Primary CD56+ NK Cells

Table 21. Global Headquarters and Manufacturing Base of Primary CD56+ NK Cells Manufacturers

Table 22. Global Major Manufacturers, Primary CD56+ NK Cells Capacity Expansion and Future Plans

Table 23. Global Primary CD56+ NK Cells Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Primary CD56+ NK Cells Production by Region, 2018-2023, (K Units)

Table 25. Global Primary CD56+ NK Cells Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Primary CD56+ NK Cells Upstream (Raw Materials)

Table 27. Global Primary CD56+ NK Cells Typical Customers

Table 28. Primary CD56+ NK Cells Typical Distributors

Table 29. By Type, Global Primary CD56+ NK Cells Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Primary CD56+ NK Cells Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Primary CD56+ NK Cells Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Primary CD56+ NK Cells Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Primary CD56+ NK Cells Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Primary CD56+ NK Cells Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Primary CD56+ NK Cells Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Primary CD56+ NK Cells Revenue Market Share, 2018-2029

Table 37. By Country, Global Primary CD56+ NK Cells Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Primary CD56+ NK Cells Sales Volume Market Share, 2018-2029

Table 39. PBM Company Information, Head Office, Market Area and Industry Position

Table 40. PBM Primary CD56+ NK Cells Models, Specifications and Application

Table 41. PBM Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. PBM Company Profile and Main Business

Table 43. PBM Recent Developments

Table 44. ATCC Company Information, Head Office, Market Area and Industry Position

Table 45. ATCC Primary CD56+ NK Cells Models, Specifications and Application

Table 46. ATCC Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. ATCC Company Profile and Main Business

Table 48. ATCC Recent Developments

Table 49. STEMCEITM Company Information, Head Office, Market Area and Industry Position

Table 50. STEMCEITM Primary CD56+ NK Cells Models, Specifications and Application

Table 51. STEMCEITM Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. STEMCEITM Company Profile and Main Business

Table 53. STEMCEITM Recent Developments

Table 54. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

Table 55. Thermo Fisher Scientific Primary CD56+ NK Cells Models, Specifications and Application

Table 56. Thermo Fisher Scientific Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Thermo Fisher Scientific Company Profile and Main Business

Table 58. Thermo Fisher Scientific Recent Developments

Table 59. AllCells Company Information, Head Office, Market Area and Industry Position

Table 60. AllCells Primary CD56+ NK Cells Models, Specifications and Application

Table 61. AllCells Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. AllCells Company Profile and Main Business

Table 63. AllCells Recent Developments

Table 64. ABM Company Information, Head Office, Market Area and Industry Position

Table 65. ABM Primary CD56+ NK Cells Models, Specifications and Application

Table 66. ABM Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. ABM Company Profile and Main Business

Table 68. ABM Recent Developments

Table 69. 3H Biomedical Company Information, Head Office, Market Area and Industry Position

Table 70. 3H Biomedical Primary CD56+ NK Cells Models, Specifications and Application

Table 71. 3H Biomedical Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. 3H Biomedical Company Profile and Main Business

Table 73. 3H Biomedical Recent Developments

Table 74. ProMab Biotechnologies Company Information, Head Office, Market Area and Industry Position

Table 75. ProMab Biotechnologies Primary CD56+ NK Cells Models, Specifications and Application

Table 76. ProMab Biotechnologies Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. ProMab Biotechnologies Company Profile and Main Business

Table 78. ProMab Biotechnologies Recent Developments

Table 79. AcceGen Company Information, Head Office, Market Area and Industry Position

Table 80. AcceGen Primary CD56+ NK Cells Models, Specifications and Application

Table 81. AcceGen Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. AcceGen Company Profile and Main Business

Table 83. AcceGen Recent Developments

Table 84. AMSBIO Company Information, Head Office, Market Area and Industry Position

Table 85. AMSBIO Primary CD56+ NK Cells Models, Specifications and Application

Table 86. AMSBIO Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. AMSBIO Company Profile and Main Business

Table 88. AMSBIO Recent Developments

Table 89. Clinisciences Company Information, Head Office, Market Area and Industry Position

Table 90. Clinisciences Primary CD56+ NK Cells Models, Specifications and Application

Table 91. Clinisciences Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Clinisciences Company Profile and Main Business

Table 93. Clinisciences Recent Developments

Table 94. Creative Bioarray Company Information, Head Office, Market Area and Industry Position

Table 95. Creative Bioarray Primary CD56+ NK Cells Models, Specifications and Application

Table 96. Creative Bioarray Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Creative Bioarray Company Profile and Main Business

Table 98. Creative Bioarray Recent Developments

Table 99. iCell Bioscience Company Information, Head Office, Market Area and Industry Position

Table 100. iCell Bioscience Primary CD56+ NK Cells Models, Specifications and Application

Table 101. iCell Bioscience Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. iCell Bioscience Company Profile and Main Business

Table 103. iCell Bioscience Recent Developments

Table 104. Shenzhen Kingfocus Biomedical Company Information, Head Office, Market Area and Industry Position

Table 105. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Models, Specifications and Application

Table 106. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. Shenzhen Kingfocus Biomedical Company Profile and Main Business

Table 108. Shenzhen Kingfocus Biomedical Recent Developments

List of Figure

Figure 1. Primary CD56+ NK Cells Picture

Figure 2. By Revenue, Global Primary CD56+ NK Cells Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Primary CD56+ NK Cells Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Primary CD56+ NK Cells Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Primary CD56+ NK Cells Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Primary CD56+ NK Cells Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Primary CD56+ NK Cells Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Primary CD56+ NK Cells Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Primary CD56+ NK Cells Share of Global Market, 2018-2029

Figure 10. Global Primary CD56+ NK Cells Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Primary CD56+ NK Cells Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Primary CD56+ NK Cells Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Primary CD56+ NK Cells Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Primary CD56+ NK Cells Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Primary CD56+ NK Cells Domestic VS Export, 2022

Figure 16. Global Primary CD56+ NK Cells Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Primary CD56+ NK Cells Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Primary CD56+ NK Cells Production Market Share & Forecast by Region, 2018-2029

Figure 19. Primary CD56+ NK Cells Industry Chain

Figure 20. Primary CD56+ NK Cells Procurement Model

Figure 21. Primary CD56+ NK Cells Sales Model

Figure 22. Primary CD56+ NK Cells Sales Channels, Direct Sales and Distribution

Figure 23. Custom Made

Figure 24. Bulk

Figure 25. By Type, Global Primary CD56+ NK Cells Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global Primary CD56+ NK Cells Revenue Market Share, 2018-2029

Figure 27. By Type, Global Primary CD56+ NK Cells Sales Volume, 2018-2029, (K Units)

Figure 28. By Type, Global Primary CD56+ NK Cells Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global Primary CD56+ NK Cells Price, 2018-2029, (US$/Unit)

Figure 30. Compound Screening

Figure 31. Immune Function Assay

Figure 32. Drug Discovery

Figure 33. Others

Figure 34. By Application, Global Primary CD56+ NK Cells Revenue, 2018-2029, US$ Million

Figure 35. By Application, Global Primary CD56+ NK Cells Revenue Market Share, 2018-2029

Figure 36. By Application, Global Primary CD56+ NK Cells Sales Volume, 2018-2029, (K Units)

Figure 37. By Application, Global Primary CD56+ NK Cells Sales Volume Market Share, 2018-2029

Figure 38. By Application, Global Primary CD56+ NK Cells Price, 2018-2029, (US$/Unit)

Figure 39. By Region, Global Primary CD56+ NK Cells Revenue Market Share, 2018-2029

Figure 40. By Region, Global Primary CD56+ NK Cells Sales Volume Market Share, 2018-2029

Figure 41. North America Primary CD56+ NK Cells Revenue & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, North America Primary CD56+ NK Cells Revenue Market Share, 2022

Figure 43. Europe Primary CD56+ NK Cells Revenue & Forecasts, 2018-2029, US$ Million

Figure 44. By Country, Europe Primary CD56+ NK Cells Revenue Market Share, 2022

Figure 45. Asia Pacific Primary CD56+ NK Cells Revenue & Forecasts, 2018-2029, US$ Million

Figure 46. By Country/Region, Asia Pacific Primary CD56+ NK Cells Revenue Market Share, 2022

Figure 47. South America Primary CD56+ NK Cells Revenue & Forecasts, 2018-2029, US$ Million

Figure 48. By Country, South America Primary CD56+ NK Cells Revenue Market Share, 2022

Figure 49. Middle East & Africa Primary CD56+ NK Cells Revenue & Forecasts, 2018-2029, US$ Million

Figure 50. U.S. Primary CD56+ NK Cells Sales Volume, 2018-2029, (K Units)

Figure 51. By Company, U.S. Primary CD56+ NK Cells Market Share, 2022

Figure 52. By Type, U.S. Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 53. By Application, U.S. Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 54. Europe Primary CD56+ NK Cells Sales Volume, 2018-2029, (K Units)

Figure 55. By Company, Europe Primary CD56+ NK Cells Market Share, 2022

Figure 56. By Type, Europe Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 57. By Application, Europe Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 58. China Primary CD56+ NK Cells Sales Volume, 2018-2029, (K Units)

Figure 59. By Company, China Primary CD56+ NK Cells Market Share, 2022

Figure 60. By Type, China Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 61. By Application, China Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 62. Japan Primary CD56+ NK Cells Sales Volume, 2018-2029, (K Units)

Figure 63. By Company, Japan Primary CD56+ NK Cells Market Share, 2022

Figure 64. By Type, Japan Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 65. By Application, Japan Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 66. South Korea Primary CD56+ NK Cells Sales Volume, 2018-2029, (K Units)

Figure 67. By Company, South Korea Primary CD56+ NK Cells Market Share, 2022

Figure 68. By Type, South Korea Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 69. By Application, South Korea Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 70. Southeast Asia Primary CD56+ NK Cells Sales Volume, 2018-2029, (K Units)

Figure 71. By Company, Southeast Asia Primary CD56+ NK Cells Market Share, 2022

Figure 72. By Type, Southeast Asia Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 73. By Application, Southeast Asia Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 74. India Primary CD56+ NK Cells Sales Volume, 2018-2029, (K Units)

Figure 75. By Company, India Primary CD56+ NK Cells Market Share, 2022

Figure 76. By Type, India Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 77. By Application, India Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 78. Middle East & Asia Primary CD56+ NK Cells Sales Volume, 2018-2029, (K Units)

Figure 79. By Company, Middle East & Asia Primary CD56+ NK Cells Market Share, 2022

Figure 80. By Type, Middle East & Asia Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 81. By Application, Middle East & Asia Primary CD56+ NK Cells Sales Volume Market Share, 2022 VS 2029

Figure 82. Research Methodology

Figure 83. Breakdown of Primary Interviews

Figure 84. Bottom-up Approaches

Figure 85. Top-down Approaches